Journals / Glokom Katarakt / 2020 / Cilt: 15 - Sayı: 3

Treatment of Uveitic Glaucoma

Pages
137–142
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In uveitic glaucoma, surgery should be planned a few months after the patients’ infl ammation is controlled as much as possible; aggressive anti-infl ammatory therapy should be applied before, during and after surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Glaucoma is a common and serious complication of uveitis.
📊
Key Findings & Data:Glaucoma surgery is required in 25-30% of eyes with uveitic glaucoma.
💡
Conclusion & Impact:In uveitic glaucoma, surgery should be planned a few months after the patients’ infl ammation is controlled as much as possible; aggressive anti-infl ammatory therapy should be applied before, during and after surgery.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Glaucoma is a common and serious complication of uveitis. In uveitic glaucoma treatment, goal is to control infl ammation and reduce intraocular pressure; thus to prevent permanent structural changes in the anterior chamber angle and optic nerve damage. Treatment should be customized according to the patient. The fi rst step in the treatment is the control of infl ammation, and if necessary, anti-infectious treatment should be added. Miotic agents should not be used as anti-glaucomatous treatment. Prostaglandin analogs can be used carefully in the absence of macular edema and active infl ammation; it should not be used in eyes with herpetic keratitis or keratouveitis. Glaucoma surgery is required in 25-30% of eyes with uveitic glaucoma. In uveitic glaucoma, surgery should be planned a few months after the patients’ infl ammation is controlled as much as possible; aggressive anti-infl ammatory therapy should be applied before, during and after surgery.

🔖

Cite This Article

ALTAN, A. C. (2020). Treatment of Uveitic Glaucoma. Glokom Katarakt, Cilt: 15 - Sayı: 3, 137–142. https://ajindex.com/articles/158873

References (15)

  1. Neri P, Azuara-Blanco A, Forrester JV. Incidence of glaucoma in patients with uveitis. J Glaucoma.2004;13:461-5
  2. Panek WC, Holland GN, Lee DA, Christensen RE. Glaucoma in patients with uveitis. Br JOphthalmol. 1990;74:223-7
  3. Merayo-Lloves J, Power WJ, Rodriguez A, et al. Secondary glaucoma in patients with uveitis. Ophthalmologica. 1999;213:300-4
  4. Agnieszka G. Nagpal, Nisha R. Acharya. Uveitic Glaucoma. Ed. Grehn F, Stamper R. In Glaucoma (Essentials in Ophthalmology Progress III) Springer-Verlag Berlin Heidelberg; 2009: 49-58
  5. Kanda T, Shibata M, Taguchi M, et al. Prevalence and aetiology of ocular hypertension in acute and chronic uveitis. Br J Ophthalmol. 2014;98:932-6
  6. Takahashi T, Ohtani S, Miyata K, et al. A clinical evaluation of uveitis associated secondary glaucoma. Jpn J Ophthalmol 2002: 46: 556–62 7. Elgin U, Berker N, Batman A. Incidence of secondary glaucoma in Behcet’s disease. J Glaucoma 2004; 13: 441-4
  7. Herbert HM, Viswanathan A, Jackson H, et al. Risk factors for elevated intraocular pressure in uveitis. J Glaucoma. 2004;13:96-9
  8. Kok H, Barton K. Uveitic glaucoma. Ophthalmol Clin North Am. 2002;15:375-87
  9. Kalogeropoulos D, Sung VC. Pathogenesis of Uveitic Glaucoma. J Curr Glaucoma Pract. 2018;12:125-138. Review
  10. Al Rubaie K, Al Dhahri H, Al Fawaz A, et al. Incidence and Risk Factors for Developing Glaucoma Among Patients with Uveitis in a University-based Tertiary Referral Center in Riyadh, Saudi Arabia. Ocul Immunol Infl amm. 2016; 24:571-8
  11. Baneke AJ, Lim KS, Stanford M. The Pathogenesis of Raised Intraocular Pressure in Uveitis. Curr 202 Eye Res. 2016;41:137-49
  12. Siddique SS, Suelves AM, Baheti U, et al. Glaucoma and uveitis. Surv Ophthalmol. 2013;58:1-10. Review
  13. Elgin U. Üveitik Glokom ve Güncel Tedavi Yaklaşımları. Glo-Kat 2016; 11:209-15 15. Wakefi eld D, Lloyd A. The role of cytokines in the pathogenesis of infl ammatory eye disease. Cytokine 1992; 4:1–5 16. Hogg P, Calthorpe M, Batterbury M, et al. Aqueous humor stimulates the migration of human trabecular meshwork cells in vitro. Invest Ophthalmol Vis Sci 2000; 41:1091-98 17. Akyol N, Turgut B. Steroid Glokomu. Glo-Kat 2006; 1:239- 44 18. Shrestha S, Thapa M, Shah DN. Pattern of intraocular pressure fl uctuation in uveitic eyes treated with corticosteroids. Ocul Immunol Infl amm. 2014;22:110-5
  14. Moorthy RS, Mermoud A, Baervedt G, et al. Glaucoma associated with uveitis. Surv Ophthalmol. 1997; 41:361–94
  15. Muñoz-Negrete FJ, Moreno-M